Pharmactive Biotech is introducing its branded ingredients to the pharmaceutical market, including its affron saffron extract, designed to support mental health. The company has appointed Paul Clayton, PhD as Chair of its scientific advisory board. Together with Pharmactive’s Medical Advisor, Carlos Galmarini, PhD, Clayton will lead this move. An ingredient for mood health, such as Pharmactive’s validated saffron extract, affron®, can be used as stand-alone or to enhance pharmaceutical products,” said Clayton. “Consumers are seeking science-based, natural mental wellness solutions and Pharmactive can answer this demand, having already pioneered in the field. The company recently published a clinical study on affron with antidepressants, and there are more to come.